Affymax, (FRA:A5Y) Market Cap : €30.74 Mil (As of Apr. 29, 2024)

View and export this data going back to . Start your Free Trial

What is Affymax, Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Affymax,'s share price for the quarter that ended in Jun. 2014 was €0. Affymax,'s Shares Outstanding (EOP) for the quarter that ended in Jun. 2014 was 37.47 Mil. Therefore, Affymax,'s market cap for the quarter that ended in Jun. 2014 was €0.00 Mil.

Affymax,'s annual market cap increased from Dec. 2011 (€172.10 Mil) to Dec. 2012 (€522.56 Mil) but then declined from Dec. 2012 (€522.56 Mil) to Dec. 2013 (€0.00 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Affymax,'s Enterprise Value for Today is €9.30 Mil.

Affymax, Market Cap Historical Data

The historical data trend for Affymax,'s Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Market Cap Chart

Affymax, Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Market Cap

Get a 7-Day Free Trial

172.10

522.56

Affymax, Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Market Cap	Get a 7-Day Free Trial															30.72	-	-	-	-

Competitive Comparison of Affymax,'s Market Cap

For the Biotechnology subindustry, Affymax,'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affymax,'s Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax,'s Market Cap distribution charts can be found below:

* The bar in red indicates where Affymax,'s Market Cap falls into.

Affymax, Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Affymax,'s Market Cap for the fiscal year that ended in Dec. 2013 is calculated as

Market Cap (A: Dec. 2013 )	=	Share Price (A: Dec. 2013 )	*	Shares Outstanding (EOP) (A: Dec. 2013 )
	=	€0	*	36.342
	=	€

Affymax,'s Market Cap for the quarter that ended in Jun. 2014 is calculated as

Market Cap (Q: Jun. 2014 )	=	Share Price (Q: Jun. 2014 )	*	Shares Outstanding (EOP) (Q: Jun. 2014 )
	=	€0	*	37.469
	=	€0.00

Affymax, (FRA:A5Y) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Affymax, Market Cap Related Terms

Thank you for viewing the detailed overview of Affymax,'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Affymax, (FRA:A5Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020

Website

http://www.affymax.com

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines